Skip to main content
S 2535 115th Congress Senate Crime and Law Enforcement Administrative law and regulatory procedures Congressional oversight Department of Justice Drug trafficking and controlled substances Drug, alcohol, tobacco use Health information and medical records

Opioid Quota Reform Act

Introduced: March 12, 2018 Introduced by: Durbin, Richard J. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 19, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 473.
Jun 19, 2018
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
May 24, 2018
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Mar 12, 2018
Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S1632)
Mar 12, 2018
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Opioid Quota Reform Act

This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to consider additional factors—the impact on overall public health and rates of diversion, abuse, and overdose deaths—in setting and adjusting production and manufacturing quotas for fentanyl, oxycodone, hydrocodone, oxymorphone, and hydromorphone.

Additionally, if the DEA increases the production quota of fentanyl, oxycodone, hydrocodone, oxymorphone, or hydromorphone, then it must explain why the public health benefits of increasing the quota outweigh the consequences of potential diversion.

What's happening now June 19, 2018

Placed on Senate Legislative Calendar under General Orders. Calendar No. 473.

 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Republican 2
R
Grassley, Chuck
Iowa · Mar 12, 2018
 R
Kennedy, John
Louisiana · Mar 12, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2535: Opioid Quota Reform Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-2535/
MLA
"S. 2535: Opioid Quota Reform Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2535/.
Bluebook (legal)
S. 2535, 115th Cong. (2026), https://openamerica.io/bill/115-S-2535/.
Markdown link
[S. 2535: Opioid Quota Reform Act](https://openamerica.io/bill/115-S-2535/)
Report a problem